Giant Cell Tumors of the Tendon Sheath: Clinical Insights and Surgical Perspectives From Three Cases
Sažetak
Giant cell tumours of the tendon sheath (GCTTS) are benign soft tissue tumours that can exhibit locally aggressive behaviour, particularly in the hand and foot. Despite their slow growth, they may cause pain and functional limitations due to compression of adjacent structures. The aim of this study was to describe the clinical presentation, diagnostic process and surgical management of three cases of GCTTS, and to assess postoperative outcomes with a focus on recurrence prevention. Three female patients aged 33, 47 and 62 years presented with progressively enlarging painful swellings in the hand or foot. Each patient underwent a full diagnostic work-up including radiography, ultrasound and magnetic resonance imaging (MRI). Complete surgical excision of the lesions was performed under regional anaesthesia. Histological analysis confirmed the diagnosis of GCTTS in all cases. Patients were followed clinically and radiologically for up to 12 months postoperatively. All patients recovered fully, with resolution of pain, restoration of joint mobility and no motor or sensory deficits. MRI follow-up at 6 and 12 months showed no evidence of tumour recurrence. Histology revealed classic features of GCTTS, including multinucleated giant cells, foamy histiocytes and hemosiderin deposits. No postoperative complications such as infection or hematoma were observed. Functional autonomy was maintained in all cases. GCTTS, while benign, requires meticulous surgical excision to prevent recurrence. Early diagnosis and complete resection result in excellent clinical and functional outcomes. Postoperative surveillance, particularly through MRI, is essential to detect any potential recurrence. Future strategies may include the use of adjuvant therapies in selected high-risk cases to further minimise recurrence risk.
Reference
Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: Radiologic-pathologic correlation. Radiographics. 2008;28(5):1493-518. doi: 10.1148/rg.285085134.
Suresh SS, Zaki H. Giant cell tumor of tendon sheath: case series and review of literature. J Hand Microsurg. 2010 Dec;2(2):67-71. doi: 10.1007/s12593-010-0020-9.
Mastboom MJL, Verspoor FGM, Verschoor AJ, Uittenbogaard D, Nemeth B, Mastboom WJB, et al; TGCT study group. Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop. 2017 Dec;88(6):688-694. doi: 10.1080/17453674.2017.1361126.
Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, et al. Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol. 2013 Oct;36(5):505-8. doi: 10.1097/COC.0b013e3182568fb6.
Cavaliere A, Sidoni A, Bucciarelli E. Giant cell tumor of tendon sheath: immunohistochemical study of 20 cases. Tumori. 1997 Sep-Oct;83(5):841-6. doi: 10.1177/030089169708300514.
Briët JP, Becker SJ, Oosterhoff TCh, Ring D. Giant cell tumor of tendon sheath. Arch Bone Jt Surg. 2015 Jan;3(1):19-21. Epub 2015 Jan 15. PMID: 25692164.
Al-Qattan MM. Giant cell tumours of tendon sheath: classification and recurrence rate. J Hand Surg Br. 2001 Feb;26(1):72-5. doi: 10.1054/jhsb.2000.0522.
Middleton WD, Patel V, Teefey SA, Boyer MI. Giant cell tumors of the tendon sheath: analysis of sonographic findings. AJR Am J Roentgenol. 2004 Aug;183(2):337-9. doi: 10.2214/ajr.183.2.1830337.
Brahmi M, Vinceneux A, Cassier PA. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis. Curr Treat Options Oncol. 2016 Feb;17(2):10. doi: 10.1007/s11864-015-0385-x.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
